Catalyst Wire Dossier Catalyst Wire Dossier

Oshadi Icp

· Oshadi Drug Administration
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Oshadi Icp, covering 2013-10-29 to 2018-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study [Phase 2]

See pricing